EP Patent

EP1315533A4 — DEVICE FOR ADMINISTERING AN INTRANASAL, PROGRAMMABLE AND MULTI-DOSE MEDICINE

Assigned to University of Kentucky Research Foundation · Expires 2007-06-27 · 19y expired

What this patent protects

Patent listed against naloxone-hydrochloride.

Drugs covered by this patent

naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.

Patent Metadata

Patent number: EP1315533A4
Jurisdiction: EP
Classification: —
Expires: 2007-06-27
Drug substance claim: No
Drug product claim: No
Assignee: University of Kentucky Research Foundation
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.